The UMSNs@phoBET1 nanocage represents a breakthrough in precision PROTAC delivery by utilizing upconversion nanoparticles (UCNPs) to convert 980 nm NIR light into localized UV activation, enabling deep-tissue BRD4 degradation with >80% tumor inhibition. Here, BRD4 is linked to neoplasm.